Indaptus Therapeutics
INDP
6 hedge funds and large institutions have $10.7M invested in Indaptus Therapeutics in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
13% more capital invested
Capital invested by funds: $9.46M → $10.7M (+$1.24M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.17M |
| 2 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
+$134K |
| 3 |
Renaissance Technologies
New York
|
+$72.8K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$60.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.29M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $4.62M | – | – | – |
|
|
MIFH
2
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
| $2.98M | +$134K | +11 | +5% |
|
|
ACP
3
Acuta Capital Partners
Redwood City,
California
| $2.28M | +$2.17M | +179 | New |
|
|
SM
4
Sabby Management
Miami Beach,
Florida
| $528K | -$2.29M | -189 | -82% |
|
|
5
Renaissance Technologies
New York
| $154K | +$72.8K | +6 | +100% |
|
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $145K | +$60.7K | +5 | +83% |
|
INDP Hedge Fund Activity: Q2 2017 in Review
6 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q2 2017, worth a combined $10.7M — up 13% from $9.46M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new INDP positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Acuta Capital Partners, opening a new position worth an estimated $2.17M. The largest seller was Sabby Management, cutting an estimated $2.29M.
- 6 institutional investors held Indaptus Therapeutics (INDP) as of Q2 2017, up from 5 in Q1 2017.
- Funds reported $10.7M of Indaptus Therapeutics stock for Q2 2017, up 13% quarter-over-quarter.
- 1 fund opened new Indaptus Therapeutics positions in Q2 2017 and 0 closed out, a net change of +1 holder.
- The largest Indaptus Therapeutics buyer in Q2 2017 was Acuta Capital Partners, an estimated $2.17M added.
- The largest Indaptus Therapeutics seller in Q2 2017 was Sabby Management, an estimated $2.29M sold.
Based on aggregated 13F filings for Q2 2017.